-
Innovation Ranking
NewInnovation Ranking – BGC Partners Inc
BGC Partners Inc (BGC Partners) is a global financial services company, providing brokerage and financial technology solutions. It provides access to a range of financial products such as interest rate swaps, fixed income securities, equity derivatives, foreign exchange, structured products, credit derivatives, and insurance brokerage. The company provides e-brokerage, post-trade services, financial technology, market data, and analytics through its e-brands such as Fenics, BGC Trader, Fenics Market Data, Lucera, and Capitalab. BGC Partners also provides broker-dealer services, trade execution and...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – BGC-0228 in Gastric Cancer
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - BGC-0228 in Gastric Cancer report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. BGC-0228 in Gastric Cancer Drug Details: BGC-0228 is under development for...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – BGC-0228 in Esophageal Cancer
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - BGC-0228 in Esophageal Cancer report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. BGC-0228 in Esophageal Cancer Drug Details: BGC-0228 is under development for...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – BGC-0228 in Breast Cancer
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - BGC-0228 in Breast Cancer report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. BGC-0228 in Breast Cancer Drug Details: BGC-0228 is under development for...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – BGC-0228 in Colorectal Cancer
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - BGC-0228 in Colorectal Cancer report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. BGC-0228 in Colorectal Cancer Drug Details: BGC-0228 is under development for...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – BGC-0228 in Small-Cell Lung Cancer
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - BGC-0228 in Small-Cell Lung Cancer report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. BGC-0228 in Small-Cell Lung Cancer Drug Details: BGC-0228 is under...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – BGC-0228 in Non-Small Cell Lung Cancer
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - BGC-0228 in Non-Small Cell Lung Cancer report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. BGC-0228 in Non-Small Cell Lung Cancer Drug Details: BGC-0228...
-
Company Insights
Innovation and Patenting activity of BGC Partners Inc Q4 2023
GlobalData, the industry analysis specialist, has released its latest company patent databook "Innovation and Patenting activity of BGC Partners Inc Q4 2023". The databook highlights patenting activity of the company in terms of growth in filings and grants, regions protected, impact of various themes, sector applicability of technologies protected. It provides contextual analysis of technical peers, their strategy, dominance (Grant share) and their recent activities. This is an on-demand databook that will be delivered upon request. The report will be...